Multicenter single arm study to evaluate safety and effectiveness of Lithoclast Trilogy in a larger number of patients.
Ten European clinical centers participate in this prospective, non-randomized trial.
Oliver Wiseman (Principal investigator), Florin Tanse, Kasra Saeb-Parsy, Nabil Atassi, Renate Endriss, Laurian Dragos, Guido Kamphuis, Daniel Pèrez Fentes, Mudhar Hassan, Marianne Brehmer, Osther Palle, Helene Jung, Ben Turney, William Finch, Neil Burgess, Stuart Irving, Evangelos Liatsikos, Thomas Knoll, and Victor Cauni